yingweiwo

HIF

HIF

HIF related products

Structure Cat No. Product Name CAS No. Product Description
BAY 87-2243 V0296 BAY 87-2243 1227158-85-1 BAY 87-2243 (BAY-87-2243) is a selective hypoxia-inducible factor-1 (HIF-1) inhibitor with potential anticancer activity.
FG-2216 (YM-311; IOX-3; YM-311) V0298 FG-2216 (YM-311; IOX-3; YM-311) 223387-75-5 FG-2216 (YM311;IOX3; YM311) is a novel, potent, and orally bioactive inhibitor of hypoxia-inducible factor-1α (HIF) prolyl 4-hydroxylase (PHD) with the potential to treat anemia.
IDF-11774 V4797 IDF-11774 1429054-28-3 IDF-11774 (IDF11774) is a novel, potent, and orally bioavailable HIF-1α (hypoxia-inducible factor 1α) inhibitor with anticancer activity.
IOX2 V0295 IOX2 931398-72-0 IOX2 is a novel and potent inhibitor of hypoxia-inducible factor (HIF-1α) prolyl hydroxylase-2 (PHD2) with considerable medical uses.
MK-8617 V2691 MK-8617 1187990-87-9 MK-8617 is a novel potent, selective, orally bioavailable pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1−3 (HIF PHD1−3), which inhibits PHD1, 2, 3 with IC50 values of 1.0, 1.0 and 14 nM, respectively.
PT2399 V13346 PT2399 1672662-14-4 PT2399 is a novel, potent, andorally bioavailable small molecule inhibitor of HIF-2 whichbinds to HIF-2α PAS B domain with an IC50 of 6 nM, exhibiting potent antitumor activity in vivo.
罗沙司他 V0293 Roxadustat (FG-4592) 808118-40-3 Roxadustat (FG4592, ASP1517) is a novel, potent and orally bioavailable inhibitor of HIF-PH (hypoxia-inducible factor prolyl hydroxylase) with the potential to treat anemia associated with chronic kidney disease (CKD).
Contact Us